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Abstract
Background: Polyphenols, a group of complex naturally occurring compounds, are widely distributed throughout the plant
kingdom and are therefore readily consumed by humans. The relationship between their chemical structure and intestinal
absorption, transport, and first-pass metabolism remains unresolved, however.
Methods: Here, we investigated the intestinal absorption and first-pass metabolism of four polyphenol compounds,
apigenin, resveratrol, emodin and chrysophanol, using the in vitro Caco-2 cell monolayer model system and in situ intestinal
perfusion and in vivo pharmacokinetic studies in rats, so as to better understand the relationship between the chemical
structure and biological fate of the dietary polyphenols.
Conclusion: After oral administration, emodin and chrysophanol exhibited different absorptive and metabolic behaviours
compared to apigenin and resveratrol. The differences in their chemical structures presumably resulted in differing affinities
for drug-metabolizing enzymes, such as glucuronidase and sulphatase, and transporters, such as MRP2, SGLT1, and P-
glycoprotein, which are found in intestinal epithelial cells.
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Introduction
Plant polyphenols—a group of complex, naturally occurring
compounds—are widely distributed throughout the plant kingdom
and are therefore readily consumed by humans. Humans are
exposed directly or indirectly to polyphenols in medicinal and
industrial applications, and in recent years interest has increased in
the potential cancer-preventative and therapeutic properties of
plant polyphenols derived from diet [1–2]. Epidemiological
evidence has long suggested that dietary intake of polyphenols,
which are abundant in fruits and vegetables, can reduce the risk of
cardiovascular disease and cancer, and even Alzheimer disease
[3–5]. A large number of mechanisms of action have been
investigated, including antioxidant properties and effects on
enzymes and signal transduction pathways in vitro and in vivo
systems [6–7].
One main problem with polyphenols is our limited understand-
ing of the relationship between their chemical structure and their
intestinal absorption characteristics and metabolic pathways,
making it difficult to understand their observed poor bioavailabil-
ity and also restricting their targeted structural modification.
Research on intestinal absorption and first-pass metabolism are a
prerequisite for understanding a possible causal relationship
between intake of polyphenols and their proposed chemopreven-
tive effect [8–9].
In the work presented here, we tested the hypothesis that both
the hydroxyl and methyl groups of polyphenol compounds affect
the metabolic stability and intestinal absorption characteristics in
rat. To address this, we selected four polyphenol compounds that
have different arrangements of hydroxyl and methyl groups:
apigenin, resveratrol, emodin and chrysophanol (Figure 1).
Emodin and chrysophanol each have one methyl group and differ
only by one hydroxyl group—emodin has three and chrysophanol
has two. Apigenin and resveratrol each have three hydroxyl
groups but no methyl groups and have very different structures.
We analyzed the pharmacokinetics of these polyphenols in rat
plasma and evaluated the contribution of the small intestine to the
absorption and first-pass metabolism of polyphenols using an
isolated small intestine perfusion system in rat, thereby allowing
the direct estimation of intestinal absorption and transport, in
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model. We were thus able to investigate the relationship between
the chemical structure and their intestinal absorption character-
istics and metabolic pathways for these compounds.
Results
Pharmacokinetic analysis following oral administration of
the polyphenols
Following oral administration, the four polyphenols were
rapidly absorbed into plasma. Figure 2 presents the plasma
concentrations of each polyphenol as a function of time.
Maximum concentrations (Cmax) for each polyphenol are observed
in the following order: chrysophanol.resveratrol.emodin.api-
genin. The double-peak phenomenon is observed in the
concentration-time (CT) curve for apigenin, emodin and resver-
atrol, but not chrysophanol, which has greater much more higher
absorption ratio, based on its area under the curve (AUC) value,
and a longer elimination half-time (Figure 2). Of the polyphenols,
the Cmax of chrysophanol was the highest, and the AUC of
resveratrol was the lowest. The intestinal absorption of intact
emodin, apigenin and resveratrol was much faster than for
chrysophanol, and the relevant pharmacokinetic parameters are
listed in Table 1 which were determined by 3P97 software.
LC/MS/MS and enzymatic hydrolysis with b-glucuronidase
and sulphatase were used to identify and quantify the glucuronide
and sulphate metabolites. After performing a full scan, individual
ion peaks were selected and their fragmentation pattern was
determined. Two of these were identified as glucuronidated (m/
z+176) and sulphated (m/z+80) derivatives of the original
compound (Figure S3). Quantitation was performed using multiple
reaction monitoring of the deprotonated precursor ion and the
related product ion after treatment with the b-glucuronidase and
sulphatase, respectively. The resulting mass chromatographic peak
areas of chrysophanol, resveratrol, emodin and apigenin increased
significantly after treatment with b-glucuronidase and sulphatase
(Figure S4) compared with the original compounds, indicating that
glucuronidated and sulphated metabolites were indeed present in
the plasma sample.
Within 1.2 h, the plasma level of apigenin glucuronides had a
Cmax value of 4363 ng/mL (Figure 2), which is higher than that
for apigenin sulphate. Resveratrol glucuronide rapidly reached its
Cmax value at 0.038 h. Compared to these compounds, the
glucuronidated metabolites of emodin and chrysophanol did not
reach their Cmax values until 4.4 and 6.4 h later, respectively. The
maximum concentration of resveratrol glucuronidates was reached
much faster than that for resveratrol sulphates compared with
other compounds whose peak level of sulphated metabolites
appeared in the plasma first, ahead of the glucuronidated
metabolites. Furthermore, only a small amount of the parent
resveratrol was detected in the plasma, and most of it appeared to
be present in the sulphated or glucuronidated metabolite form.
The Cmax and AUC of sulphated resveratrol were highest for the
sulphated metabolites, and the AUC of chrysophanol glucuronides
was higher than any other glucuronidated metabolite. The amount
of derivatized metabolite detected, as a fraction of the original
compound, was ranked as follows: resveratrol.apigenin.chryso-
phanol.emodin; thus the percentage of parent emodin in the
plasma was much higher than that for the other polyphenols.
Absorption and first-pass metabolism in the isolated
intestine model
The rate of intestinal absorption and first-pass metabolism may
also play an important role in determining the transport dynamics
of the polyphenol compounds. To test the importance of intestinal
metabolizing enzymes that are also involved in this metabolic
process, we used an intestinal perfusion model in situ. Glucuro-
nides and sulphates were identified and quantified as described in
Methods. The amounts of derivatized compounds were deter-
mined indirectly by measuring the amounts of un-derivatized
compounds following enzymatic cleavage of the derivatives by
incubation of the luminal and vascular effluents (Table 2).
Approximately 29% of the administered apigenin re-appeared at
the vascular side—predominantly as free apigenin (16%)—but
Figure 1. Chemical structures of the polyphenol compounds.
doi:10.1371/journal.pone.0029647.g001
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e29647Figure 2. Time-dependent appearance of the polyphenol compounds and their metabolites in plasma after oral administration to
rat. (A) apigenin, glucuronidated apigenin and sulphated apigenin, (B) resveratrol, glucuronidated resveratrol and sulphated resveratrol, (C) emodin,
glucuronidated emodin and sulphated emodin, (D) chrysophanol, glucuronidated chrysophanol and sulphated chrysophanol, (mean 6 SD, n=6). (N)
Parent polyphenols, (&) glucuronidated polyphenols, (m) sulphated polyphenols.
doi:10.1371/journal.pone.0029647.g002
Table 1. Pharmacokinetic parameters of polyphenol compounds and their metabolites in rat plasma after oral administration.
Compounds Pharmacokenitic parameters
K (h
21) T1/2Ke (h) Tpeak (h) Cmax (ng/mL) AUC (ngNh/mL)
Apigenin 0.1660.02
1 2.1160.03 0.5060.01 4262 659625
Glucuronidated apigenin 0.1460.01 4.6960.05 1.2360.13 4364 351613
Sulfated apigenin 0.0660.01 10.9760.13 1.0760.09 13622 0 62
Resveratrol 0.3860.03 1.8260.05 0.1760.02 157613 9867
Glucuronidated resveratrol 0.3160.01 2.2160.11 0.0360.01 9467 305613
Sulfated resveratrol 0.1660.02 4.0960.23 0.2260.03 5663 350624
Emodin 0.2360.04 2.9360.04 0.5060.01 7266 809617
Glucuronidated emodin 0.1460.03 4.8360.17 4.4860.14 2862 38763
Sulfated emodin 0.3560.01 1.9260.25 0.3360.05 1260.5 3861
Chrysophanol 0.0860.01 8.0060.28 3.0060.01 326618 1721657
Glucuronidated chrysophanol 0.1360.02 5.2360.47 6.4560.24 6761 1194639
Sulfated chrysophanol 0.1560.01 4.5560.35 1.3260.08 960.3 7264
1mean 6 SD (all such values); n=6.
doi:10.1371/journal.pone.0029647.t001
Polyphenol Metabolism in Rat and in Caco-2 Cells
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29647some apigenin glucuronides (9%) and sulphates (4%) were also
detected. The main compound in the luminal effluent was the
unmodified apigenin, with lesser amounts of apigenin glucuronides
(13%) and sulphates (2%). For chrysophanol, 14% and 2% of
glucuronides and sulphates, respectively, were detected at the
vascular side; at the luminal side, 9% were chrysophanol
glucuronides and 4% were sulphates. Glucuronidated and
sulphated resveratrol was detected at the vascular side (16% and
24% respectively), and at the luminal side (5% and 7%
respectively).
Taken together with our earlier findings [10], following
perfusion in the intestine, resveratrol was metabolized to the
greatest extent, whereas only a small amount of emodin was
metabolized. This is consistent with the AUC results of plasma
concentrations following oral administration of the polyphenols:
only a small amount of resveratrol was detected whereas emodin
was detected in the greatest amounts. In addition, apigenin was
metabolized to a similar extent as chrysophanol, although less
parent compound was present on the vascular side. This is
consistent with the AUC results of plasma concentrations following
oral administration of apigenin and chrysophanol, with apigenin
giving rise to a smaller AUC value. After first-pass metabolism, the
percentage of resveratrol sulphates was higher than resveratrol
glucuronides, and the majority of resveratrol metabolites were
transferred to the vascular side. In contrast, the bulk of emodin,
chrysophanol and apigenin metabolites were glucuronides that
were detected in greater amounts at the luminal side compared to
the vascular side (Figure 3). The control perfusion experiments, in
which no polyphenols were added to the perfusion media, no
polyphenols or their metabolites were detected.
Transport of polyphenols through Caco-2 cells
We have previously shown that polyphenol compounds can be
absorbed rapidly by Caco-2 cells [11]. After intracellular
accumulation of these parent compounds, the Cmax values were:
chrysophanol.resveratrol.emodin.apigenin. The Cmax of api-
genin, chrysophanol and emodin was 10 min, but the intracellular
accumulation of resveratrol increased in a time-dependent manner
(Figure S5). After incubation with the Caco-2 cells for 1 h, the
polyphenol compounds were metabolized by the phase II enzyme
extensively. For emodin and chrysophanol, the predominant
metabolites were still the glucuronides, but for resveratrol and
apigenin there were no obvious differences between the amounts
of glucuronides and sulphates (Figure 4a). This is in agreement
with results from plasma and the isolated intestine samples.
Since Caco-2 is an in vitro model for the intestinal absorption, it
is necessary to know how the parent compounds are transferred in
Caco-2 cells in both directions firstly. So to observe the divergence
in the transport processes of the polyphenol compounds and their
metabolites, we monitored the directional movement of the intact
parent compounds, glucuronide and sulfate derivatives in Caco-2
cells from apical to basolateral and from basolateral to apical
directions, and the permeability values of the parent polyphenol
and their metabolites were calculated from different direction.
There were no changes in the permeability value for apigenin in
either direction, but for emodin and chrysophanol the permeabil-
ity value from BL to AP was much greater (by a factor of two) than
that from AP to BL (p,0.01). The permeability value of
resveratrol from BL to AP was lower than that from AP to BL
(p,0.05) (Table 3). For all polyphenols, the metabolites had higher
permeability values in the AP to BL direction than in the opposite
direction, except for sulphated resveratrol, for which the
permeability value was independent of the direction (Figure 4b).
To test the effects of the integral-membrane transporters on the
absorption and transport of these polyphenol compounds, the
intracellular accumulation of the polyphenol compounds was
investigated in the absence or presence of verapamil, cyclosporine
A, and phloridzin. The intracellular accumulation of apigenin and
resveratrol clearly increased after pre-treatment with verapamil
and cyclosporine A, but no changes were observed in the presence
of phloridzin. We have previously shown that phloridzin, as a
competitive inhibitor of SGLT1, can reduce the uptake of emodin
and chrysophanol, It is interesting to note that phloridzin inhibits
the uptake of emodin and chrysophanol, but not that of apigenin
and resveratrol. Structurally the latter two compounds appear to
bear some resemblance to phloridzin whereas the former two
compounds do not. Here, however, verapamil and cyclosporine
also increased the uptake of emodin and chrysophanol in a dose-
dependent manner (Figure 4c). The inhibitors therefore appeared
to dramatically affect the intracellular concentration of polyphenol
compounds, indicating that the intracellular accumulation and
transport processes of the polyphenol compounds in intestinal
epithelial cells is regulated by these transporters.
Discussion
Polyphenols are widely available as dietary supplements in
pharmacies and health food stores [12]. Although the increasing
evidence for the possible pharmacological effects of plant
polyphenols on human health have been largely substantiated,
concerns about their in vivo activity, especially regarding the
relationship between their chemical structure and intestinal
absorption, first-pass metabolism, or bioavailability remain
unresolved. To address this issue, sensitive and reliable analytical
methods capable of measuring polyphenols and their metabolism
were developed and successfully used to determine oral bioavail-
ability of polyphenols in vivo, pharmacokinetics studies using rats,
absorption and first-pass metabolism mechanisms using in situ
intestinal perfusion, and transport across Caco-2 cell monolayers.
All of the polyphenol compounds and their metabolites can be
absorbed into the circulation rapidly after oral administration and
exhibit different transport dynamics according to their chemical
structures. The reason for high amounts of resveratrol absorption
Table 2. Distribution of polyphenol compounds and their
metabolites in the luminal and vascular compartments after
perfusion experiments to rat small intestine.
Compounds Luminal effluent Vascular side
nmol % nmol %
Apigenin
1 813634
3 53.87
2 247619 16.39
2
Glucuronidated apigenin 195617 12.93
2 131614 8.70
2
Sulfated apigenin 2862 1.83
2 5768 3.79
2
Resveratrol 536627 35.37
2 193611 12.74
2
Glucuronidated resveratrol 7465 4.90
2 243610 16.04
2
Sulfated resveratrol 10567 6.90
2 364613 24.03
2
Chrysophanol 559657 36.82
2 489622 32.22
2
Glucuronidated chrysophanol 131612 8.63
2 210614 13.83
2
Sulfated chrysophanol 6668 4.34
2 3864 2.48
2
1polyphenol compounds (1500 nmol) were applied in perfusion experiments of
60 min, respectively.
2refers to amount of delivered dose (%).
3mean 6 SD (all such values); n=3.
doi:10.1371/journal.pone.0029647.t002
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permeable substance. Furthermore, resveratrol absorption usually
yields cis and trans isomers, and the amount of cis isomer formed
also depends on the stability of the applied formulation. Plasma
concentrations of glucuronidated metabolites were estimated to be
20-fold and 10-fold greater than that of the sulphated metabolites
for chrysophanol and emodin, respectively. For apigenin and
resveratrol, there are no clear differences between the fraction of
Figure 3. Time-dependent appearance of polyphenols and their metabolites in the luminal and vascular compartments after
perfusion experiments with rat small intestine. (A) Apigenin, (C) chrysophanol, (E) resveratrol and their derivatives in the vascular
compartments after perfusion experiments of chrysophanol with rat small intestine. (B) Apigenin, (D) chrysophanol, (F) resveratrol derivatives in the
luminal compartments after perfusion experiments, (mean 6 SD, n=3). (N) Parent polyphenols, (&) glucuronidated polyphenols, (m) sulphated
polyphenols.
doi:10.1371/journal.pone.0029647.g003
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that the free hydroxyl groups of the latter polyphenols can give rise
to very rapid derivatization by glucuronidation and sulphation,
which arise from the hepatic or intestinal metabolic processes. In
addition, the methyl groups of chrysophanol and emodin may
hamper the production of the sulphated metabolite and increase
the possibility of an interaction between the hydroxyl groups and
glucuronide enzyme.
Systemic blood sampling cannot completely determine the
contribution of the intestinal first-pass metabolism during the
absorption of a drug or chemical, however. We therefore also used
in situ intestinal perfusion in rat—a more reliable technique to
investigate drug absorption potential, in combination with
intestinal metabolism [13]. We used an isolated preparation of a
vascularly and luminally perfused small intestine of a rat to assess
the intestinal absorption and first-pass metabolism of these
polyphenol compounds.
From these experiments, apigenin, resveratrol and emodin
showed a higher percentage of parent drug in the luminal side and
only a small amount was transferred into blood circulation after
the first contact with enterocytes. There was no obvious difference
for the concentration of parent chrysophanol between the luminal
side and the vascular side, and the highest percentage of parent
polyphenol was found in the vascular side. This is in agreement
Figure 4. Transport and metabolism in Caco-2 cells. Intracellular accumulation of polyphenol compounds and their metabolites, (a1) apigenin
and metabolites, (a2) resveratrol and metabolites, (a3) emodin and metabolites, (a4) chrysophanol and metabolites. Transport of glucuronides and
sulphates from different directions in Caco-2 cells (nmol/LN mg N protein), (b1) glucuronides from AP to BL, (b2) sulphates from AP to BL, (b3)
glucuronides from BL to AP, (b4) sulphates from BL to AP. The effect of different inhibitors (100 mM verapamil,100 mM cyclosporine A, 50 mM
phloridzin) on the transport of polyphenol compounds in Caco-2 cells; (c1) apigenin, (c2) resveratrol, (c3) emodin, (c4) chrysophanol. (mean 6 SD,
n=6).
doi:10.1371/journal.pone.0029647.g004
Polyphenol Metabolism in Rat and in Caco-2 Cells
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29647with that the observation that, compared to the other polyphenols,
chrysophanol showed the highest AUC and Cmax after oral
administration.
In our current experiments with the isolated intestinal model, all
of the parent compounds appeared to be metabolized extensively by
the phase II enzymes in rat intestine. A fraction of the
glucuronidated or sulphated polyphenols was absorbed into the
blood,and the remainderwaseffluxedbacktotheluminalside.This
experimental system allows the study of transepithelial transport
and metabolism separately from processes taking place in vivo in the
intestinallumen, blood orliver. Thepresence of glucuronidated and
sulphated metabolites in the vascular side of the small intestine of
rats after perfusion of the polyphenols also shows that glucuronida-
tion and sulphation of polyphenols occurs first in the enterocytes
before further derivatization in the liver. These results strongly
support previous evidence that most polyphenols are extensively
metabolized and derivatized during transfer from the gut lumen to
the serosal surface. It is noteworthy, however, that glucuronyl
transferase or sulphate transferase may also play an important role
in the first-pass metabolism of most polyphenols in the small
intestine. This may ultimately reduce the bioavailability, and thus
the efficacy, of orally administered polyphenols.
Furthermore, for apigenin and emodin, the total percentages of
parent compounds and metabolites were estimated to be about
two- to three-fold greater in the luminal side than in the vascular
side. For chrysophanol and resveratrol, however, there were no
clear differences in the concentration of parent compounds or
metabolites between the luminal and vascular sides. We infer that
the differences in chemical structure between these compounds
and their metabolites is a factor that explains their different
affinities for the transporters, including MRP2, SGLT1, and P-
glycoprotein, all of which were found in the membranes of
intestinal epithelial cells.
Because of its similarity to the human intestinal epithelium, the
Caco-2 cell culture model has been widely used to determine
intestinal transport and metabolism mechanisms for drug
candidates and dietary chemicals [14–15]. Here, we used human
Caco-2 cells to examine the relative transport of dietary
polyphenols to gain insight into the mechanisms governing their
absorption and metabolism processes in intestinal epithelial cells.
We found that a specific transport system mediates the
translocation of these polyphenol compounds across the apical
membrane in Caco-2 cells. Phloridzin reduced the cellular uptake
of emodin and chrysophanol in Caco-2 cells but had no effect on
the intracellular absorption of apigenin and resveratrol. This
suggests that emodin and chrysophanol can be absorbed and
transferred via SGLT1. Both cyclosporine A and verapamil
increased the uptake of these polyphenol compounds in Caco-2
cells, which means that MRP2 and P-glycoprotein were also the
transporters for these compounds. In addition, this may partly be
the reason for the double peak shown in the absorption of the
polyphenol in plasma after oral administration. Usually, polyphe-
nolic compounds metabolize in the enterocytes and are effluxed
back into intestinal lumen by MRP-2/Pgp and in the lumen, these
metabolites could be de-conjugated either by bacterial enzymes or
enzymes from the desquamated cells, which could give rise for
double peak. Also, this could occur in vivo in colon owing to
metabolite excretion by bile and the re-absorption of parent
compounds in the lower parts. Therefore, strategic application of
intestinal P-glycoprotein, MRP2 and SGLT1 inhibitors may
therefore modulate the oral therapeutic effect of these polyphenols.
The current study investigated the intestinal absorption and first-
pass metabolism mechanism of four polyphenol compounds using
the Caco-2 monolayer model, the rat in situ intestinal perfusion
model, and in vivo pharmacokinetics in rat. Many studies have
shown that the poor bioavailability of dietary polyphenols is
dependent on the number of free hydroxyl groups, making them
highly susceptible to glucuronidation and sulphation. This study
also provides fundamental information on the relationship between
the chemical structure of these polyphenols and their absorption
characteristics and metabolic pathways in the intestine, and
demonstrates that methyl groups of dietary polyphenols may result
not only in a dramatic increase in their intestinal metabolic stability
but also in a large improvement in their intestinal absorption—both
of which should greatly increase their oral bioavailability. In
addition, this study shows the usefulness of the intestinal perfusion
model and intestinal Caco-2 cell monolayer, combined with in vivo
pharmacokinetics studies, as effective methods to establish these
properties. This investigation and with further structural modifica-
tion, occurring in certain plants, provides insight into finding ways
to improve the intestinal absorption of dietary polyphenols and the
potential for the design of new therapeutic target drugs.
Materials and Methods
Ethics Statement
All procedures had the approval of the Animal Ethics
Committee of the Fourth Military Medical University.
Reagents and chemicals
Apigenin, chrysophanol, emodin, resveratrol and phloridzin
were purchased from the National Institute for the Control of
Pharmaceutical and Biological Products (Beijing, China) in the
highest available purity (98%, as determined by high-performance
liquid chromatography; HPLC). Due to their hydrophobicity and
poor solubility in water, these polyphenol compounds were
dissolved in dimethyl sulphoxide (DMSO) to give a solution of
final concentration 0.1% v/v. Verapamil, cyclosporine A, b-
glucuronidase and sulphatase were purchased from Sigma (St.
Louis, MO, USA). All chemicals and reagents were of analytical
grade or HPLC grade.
Animals
Male Sprague-Dawley rats (70–110 days old) weighing between
270 g and 320 g were obtained from the experimental animal
centre of the Fourth Military Medical University, Xi’an, China.
The rats were subjected to fasting overnight, with free access to
water before the day of experiment.
Oral administration of polyphenols
The polyphenol compounds solution, prepared in 0.5% sodium
carboxyl methyl cellulose (CMC-Na), were orally administrated to
Table 3. Permeability (Papp) of polyphenol compounds.
Polyphenols Papp (cmNs
21N10
26)
AP to BL BL to AP
Apigenin 13.8361.21
1 12.9162.54
Chrysophanol 10.8162.34 27.3864.19
2
Emodin 9.5261.45 24.4563.22
2
Resveratrol 11.2963.45 7.8662.67
3
1mean 6 SD (all such values); n=6.
2Student’s t test. Significantly different from the AP to BL direction, p,0.01.
3Student’s t test. Significantly different from the AP to BL direction, p,0.05.
doi:10.1371/journal.pone.0029647.t003
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–1. Blood samples were
collected from the vena abdominalis under light ether anaesthesia at
different times (0.08, 0.17, 0.5, 1, 2, 4, 8, 12, 16, 24 and 36 h). The
samples were immediately centrifuged for 10 min at 7185 g to
obtain plasma, which was then frozen at 270uC until required for
analysis.
In situ intestinal perfusion model
The rats were anaesthetized with an intra-abdominal injection
of a mixture containing 40 mgNkg
–1 sodium phenobarbital. The
animals were then heparinized (90 UNkg
–1) via the vena caudalis.
The small intestine was prepared as described [16–17]. Briefly, a
segment of intestine between 7 and 11 cm long was identified and
separated and silicone tubing was placed inside both ends of the
segment. The tube at the proximal side was connected to a
peristaltic pump for luminal perfusion. A polyethylene cannula,
connected to a peristaltic pump for vascular perfusion, was
inserted into the superior mesenteric artery. The solutions on both
sides were circulated with 95% O2 and 5% CO2 for the duration
of the transport studies. Samples were obtained from the outlet of
the mesenteric vein, and luminal aliquots were collected into
preweighed microtubes every 10 min and stored at 270uC until
needed for analysis.
Cell experiments
Caco-2 cells, derived from human colorectal adenocarcinoma
cells, were obtained from the American Type Culture Collection
(Manassas, VA, USA) and maintained in plastic culture flasks
(Corning Costar, Cambridge, MA, USA). The cells were cultured
in Dulbecco’s modified Eagle’s minimal essential medium
supplemented with 1% non-essential amino acids, 1% L-gluta-
mine, 20% foetal bovine serum, 100 UNmL
–1 penicillin, and
0.1 mgNmL
–1 streptomycin, and were grown in a humidified
atmosphere of 5% CO2 in air at 37uC (Figure S1). Cells were
subcultured to 80% confluency [18].
For all cellular uptake studies of polyphenols, Caco-2 cells were
seeded at a cell density of 6610
5 cellsNcm
–2 on six-well plastic plates.
Cells were used 14 to 21 days afterseeding.The culturemediumwas
replaced with fresh medium 24 h before the uptake experiments.
Polyphenol compounds (50 mM) were added to evaluate the uptake
characteristics of Caco-2 cells. To determine the intracellular
concentration of polyphenols, the cell lysate was obtained by
subjecting the drug-containing cells to three freeze-thaw cycles in
liquid nitrogen. Protein concentrations were measured using the
Bradford method with bovine serum albumin as a standard.
For transport experiments, Caco-2 cells were seeded at a cell
density of 1610
5 cellsNcm
22 on Millicell Cell Culture Inserts
(Millipore, Billerica, MA, USA). Cells were used 19 to 21 days after
seeding, by which time the transepithelial electrical resistance value
was .300 VNcm
–2. The culture medium was replaced with fresh
medium 24 h before the transport experiments. Polyphenol
compounds (50 mM) were added from the apical or basolateral side
to evaluate the transport characteristics of the cells. To investigate the
role of different transporters, Caco-2 cells were preincubated with
verapamil (an inhibitor of P-glycoprotein), cyclosporine A (a dual
inhibitor of P-glycoprotein and multi-drug resistance protein 2,
MRP2), or phloridzin, (a selective inhibitor of sodium/glucose
cotransporter 1, SGLT1) to investigate the absorptive and transport
changes of the polyphenol compounds [19–20]. The samples were
collected and stored at 270uC until needed for analysis.
Sample preparation and quantitative analysis
Metabolite samples were analyzed after treatment with b-
glucuronidase or sulphatase [21–22]. The samples (0.2 mL) were
extracted with 1 mL ethyl acetate by vigorous vortex mixing for
1 min, then centrifuged at 30006 g at room temperature for
10 min. The supernatants were evaporated to dryness under N2,
reconstituted in 100 mL of methanol, and analyzed for the
presence of polyphenols and their derivatives using liquid
chromatography coupled with tandem mass spectrometry (LC/
MS/MS) using a Quattro Premier system operating under
MassLynx MS Software, v4.1 (Waters Corporation, Milford,
MA, USA). We developed a high-throughput and sensitive
bioanalytical method to estimate the concentration of polyphenol
compounds and their metabolites using LC and electrospray
ionization MS/MS to generate negative ions [M-H]
–. Quantita-
tion was performed by multiple reaction monitoring of the
deprotonated precursor ion and the related product ion for these
polyphenols using the internal standard method with peak area
ratio [23–24]. Collision-induced dissociation was achieved using
argon as the collision gas. Standard solutions of the polyphenol
compounds (1 mgNmL
–1) were applied to optimize the detection
conditions in the presence of mobile phase. The mass transitions
were m/z 269.4R225.4 for emodin, m/z 253.3R225.2 for
chrysophanol, m/z 268.9R116.8 for apigenin, and m/z
226.9R142.8 for resveratrol (Table S2, Figure S2). The
polyphenols were separated on a reverse phase C18 column
(Symmetry C18 column, 5 mm, 2.1650 mm, Waters Corporation,
Milford, MA, USA) using an isocratic mobile phase consisting of
10% of 0.1% aqueous acetic acid/90% of 0.1% acetic acid in
acetonitrile (v/v) for emodin and chrysophanol, and 40% of 0.1%
aqueous acetic acid/60% of 0.1% acetic acid in acetonitrile (v/v)
for resveratrol and apigenin (Table S1). The column temperature
and flow rate were 25uC and 0.2 mL?min
–1, respectively.
Supporting Information
Figure S1 Caco-2 cells for uptake and transport studies.
(EPS)
Figure S2 MassPrecursor/product ion mass spectra of
polyphenols. (a1) Apigenin, m/z 268.7; (a2) Daughter of apigenin,
m/z 268.5R116.8; (b1) Resveratrol, m/z 226.9; (b2) Daughter of
resveratrol, m/z 226.9R142.8; (c1) Emodin, m/z 269.4; (c2)
Daughter of emodin, m/z 269.1R2 25.1; (d1) Chrysophanol, m/z
253.5; (d2) Daughter of chrysophanol, m/z 253.4R225.2.
(EPS)
Figure S3 Precursor/product ion mass spectrum of the
polyphenol metabolites. (a1) Glucuronidated apigenin precur-
sor ion mass spectrum, m/z 446. (a2) Daughter ion of glucuroni-
dated apigenin, m/z 446R268.6. (a3) Sulphated apigenin precursor
ion mass spectrum, m/z 349.7. (a4) Daughter ion of sulphated
apigenin, m/z 349.7R268.5. (b1) Glucuronidated resveratrol
precursor ion mass spectrum, m/z 402.7. (b2) Daughter ion of
glucuronidated resveratrol, m/z 402.7R226.8. (b3) Sulphated
resveratrol precursor ion mass spectrum, m/z 306.9. (b4) Daughter
ion of sulphated resveratrol, m/z 306.9R226.7. (c1) Glucuronidated
emodin precursor ion mass spectrum, m/z 446. (c2) Daughter ion of
glucuronidated emodin, m/z 446R269.6. (c3) Sulphated emodin
precursor ion mass spectrum, m/z 349.7, (c4) Daughter ion of
sulphated emodin, m/z 349.7R269.3. (d1) Glucuronidated chryso-
phanol precursor ion mass spectrum, m/z 429.5. (d2) Daughter ion
of glucuronidated chrysophanol, m/z 429.5R253.7. (d3) Sulphated
chrysophanol precursor ion mass spectrum, m/z 333.2. (d4)
Daughter ion of sulphated chrysophanol, m/z 333.7R253.6.
(EPS)
Figure S4 Multiple reaction monitoring chromato-
grams of compounds and internal standard after
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29647treatment with b-glucuronidase or sulphatase. The
retention times were different for the polyphenols after separation
ona reversed-phase columnwith an isocratic mobile phase, apigenin
(1.82 min), resveratrol (1.30 min), emodin (1.17 min) and chryso-
phanol (1.57 min), respectively. (a1) Apigenin, (a2) glucuronidated
apigenin, (a3) sulphated apigenin, (b1) resveratrol, (b2) glucuroni-
dated resveratrol, (b3) sulphated resveratrol, (c1) emodin, (c2)
glucuronidated emodin, (c3) sulphated emodin, (d1)c h r y s o p h a n o l ,
(d2) glucuronidated chrysophanol, (d3) sulphated chrysophanol.
(EPS)
Figure S5 Time course for the intracellular accumula-
tion of apigenin and resveratrol in caco-2 cells.
(EPS)
Table S1 HPLC condition.
(DOC)
Table S2 Mass spectrum condition.
(DOC)
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